Glatiramer Acetate (GA) in Patients With a First Episode of Acute Optic Neuritis

Study Title
A Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Effects of Glatiramer Acetate (GA) on the Retinal Nerve Fiber Layer (RNFL) and Visual Function in Patients With a First Episode of Acute Optic Neuritis (AON). (Octagon)
Teva Identifier
PM030
ClinicalTrials.gov Identifier
NCT00856635
Study Status
Completed
Trial Condition(s)
Optic Neuritis
Interventions
Drug: Glatiramer Acetate | Drug: placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 45 Years
Trial Duration
02/01/2009 - 02/01/2011
Phase
Phase 3

Study Type

Interventional